Automated description from the Alliance of Genome Resources (Release 4.0)
Predicted to have chromatin binding activity and peroxisome proliferator activated receptor binding activity. Predicted to be involved in animal organ morphogenesis; negative regulation of lipid biosynthetic process; and positive regulation of transcription by RNA polymerase II. Predicted to localize to PR-DUB complex. Is expressed in heart. Orthologous to human ASXL3 (ASXL transcriptional regulator 3).